Low-energy shock wave therapy ameliorates erectile dysfunction in a pelvic neurovascular injuries rat model

Currently available pharmacological erectile dysfunction (ED) treatments improve erectile function when impaired, yet none are curative. The search for a disease-modifying treatment for ED is the goal of this coming decade, with the advent of promising therapeutic strategies such as gene therapy and stem cell regeneration, while attempts for rehabilitation treatment protocols in men with ED using chronic phosphodiesterase-5-inhibitors (PDE5-Is) i.e., after radical prostatectomy have failed. However, data on the therapeutic benefits of these treatments to restore erectile function are still scarce. Pioneer clinical studies reporting the use of low-intensity extracorporeal shock wave therapy (Li-ESWT) have shown that Li-ESWT could improve erectile function and penile hemodynamics in men with ED who respond to pharmacotherapy and convert PDE5-I non-responders to responders (1-4). More clinical studies have been conducted since then revealing encouraging results, such as the improvement of International Index of Erectile Function score and/or Erectile Hardness Score and an effect that lasts up to 1 year (5-10). Therefore, it seems that Li-ESWT has the potential to become the first non-invasive curative treatment for ED patients (11-13).

These exciting clinical proof-of-concept studies trigger many questions, among which the mechanism of action of Li-ESWT responsible for this beneficial effect on erectile function. To date, however, very few preclinical studies have been led to investigate these aspects (14-16). Of note, all these studies report positive effects of Li-ESWT on erectile function whatever the experimental ED model used. Moreover, several hypotheses for Li-ESWT’s mechanisms of action in erectile function recovery have been inspired by previous studies conducted in other basic science fields. It was thus shown that Li-ESWT triggers the activation of various intracellular signaling pathways causing upregulation of numerous angiogenic factors (i.e., VEGF…) to promote neovascularization and mobilizes the recruitment of endogenous progenitor cells thereby favoring angiogenesis and tissue regeneration in cardiovascular medicine and wound healing (17-21). These pro-angiogenic signaling pathways and recruitment of endogenous progenitor cells have also been shown to be activated in the penile tissue following Li-ESWT treatment in diabetic ED models (15,16), despite the fact that it does not upregulate the NO/cGMP pathway (14). Moreover, the role of Li-ESWT in the regeneration of peripheral nerves has also been previously suggested after nerve compression or in a model of autologous nerve graft (22,23) and later investigated in the context of erectile function recovery in diabetic ED models (15,16).

In this study (24), Tom Lue and his colleagues investigated the effects of two different treatment regimen using Li-ESWT (low energy: 0.06 mJ/mm², 300 pulses, 3 Hz during 4 weeks and 1 week wash-out or high energy: 0.09 mJ/mm², 1,000 pulses, 3 Hz during 4 weeks and 1 week wash-out) in a new experimental model of neurovascular ED produced by both bilateral cavernous nerve injury (CNI) and internal pudendal bundle (IPB) injury. This model is meant to mimic trauma-related ED that “commonly occurs in the setting of pelvic surgery or as a result of local injuries such as improvised explosive device in battlefield […]”. Patients suffering from this form of ED are often not responsive to standard of care such as PDE5-Is and represent difficult-to-treat patients. In this study, Li-ESWT at both “low energy” and “high energy” is successful at improving erectile response to cavernous nerve stimulation. Demonstration of penile angiogenesis, tissue restoration, and penile nerve regeneration including nNOS-positive nerve fibers coinciding with recruitment of endogenous progenitor cells to the damaged area was obtained. Moreover, both dedifferentiation and proliferation of Schwann cells at the site of pelvic injury was evidenced, further supporting the concept of nerve regeneration.

Shock waves are acoustic waves characterized by high pressure amplitudes and an abrupt increase in pressure in comparison to the ambient pressure. There are various medical devices delivering shock waves, using various techniques [Radial pressure wave (RSWT), electrohydraulic, electromagnetic or piezoelectric shockwave] and equipped with a focused, soft-focused and/or unfocused reflector depending on the indication and the tissue that shall be treated. Thus, these technologies differ in the manner in which the shockwaves are produced, the ability of the shockwave to be controlled and focused, the depth to which the shockwaves can penetrate, and the overall amount of energy being produced.

Therefore, results obtained in a study with a specific device/protocol do not allow for extrapolation on different devices or setups. It is particularly the case when investigating Li-ESWT in a preclinical setting, since particular care is needed to adapt the equipment to the size of the experimental model used. Thus, care to reduce the loss of energy between the shockwave electrode and the targeted tissue is mandatory. Intensity, duration of each session and total number of sessions may need to be determined according to the kind of equipment, and it is of paramount importance that measurement of the actual amount of energy delivered to the targeted site is performed, in order to mimic as closely as possible the amount of energy which is delivered to patients.

In this study, it is inferred that these treatments were applied once a week although this information was not provided. Moreover, the focused shockwave source was delivered to the “pelvic region” of the rat. Has the actual amount of energy been measured on the targeted site and how does this setting compare to the delivery of Li-ESWT to the penile shaft of ED patients receiving Li-ESWT treatment?

In any case, it should be emphasized that such experimental studies on the use of Li-ESWT are very rare and time-consuming. As such, these data are a very valuable contribution in the understanding of the mechanistic actions of Li-ESWT in an experimental setting of ED. Thus, Li and co-workers (24) should be both congratulated for this work and encouraged to pursue this line of much-needed basic science research.

Acknowledgements

None.

Footnote

Conflicts of Interest: The authors have no conflicts of interest to declare.

References

1. Gruenwald I, Appel B, Vardi Y. Low-intensity extracorporeal shock wave therapy--a novel effective treatment for erectile dysfunction in severe ED patients who respond poorly to PDE5 inhibitor therapy. J Sex Med 2012;9:259-64. [Crossref] [PubMed]
2. Vardi Y, Appel B, Kilchevsky A, et al. Does low intensity extracorporeal shock wave therapy have a physiological effect on erectile function? Short-term results of a randomized, double-blind, sham controlled study. J Urol 2012;187:1769-75. [Crossref] [PubMed]
3. Vardi Y, Appel B, Jacob G, et al. Can low-intensity extracorporeal shockwave therapy improve erectile function? A 6-month follow-up pilot study in patients with organic erectile dysfunction. Eur Urol 2010;58:243-8. [Crossref] [PubMed]
4. Yee CH, Chan ES, Hou SS, et al. Extracorporeal shockwave therapy in the treatment of erectile dysfunction: a prospective, randomized, double-blinded, placebo controlled study. Int J Urol 2014;21:1041-5. [Crossref] [PubMed]
5. Chung E, Cartmill R. Evaluation of clinical efficacy, safety and patient satisfaction rate after low-intensity extracorporeal shockwave therapy for the treatment of male erectile dysfunction: an Australian first open-label single-arm prospective clinical trial. BJU Int 2015;115 Suppl 5:46-9. [Crossref] [PubMed]
6. Frey A, Sønksen J, Fode M. Low-intensity extracorporeal shockwave therapy in the treatment of postprostatectomy erectile dysfunction: a pilot study. Scand J Urol 2016;50:123-7. [Crossref] [PubMed]
7. Bechara A, Casabé A, De Bonis W, et al. Twelve-Month Efficacy and Safety of Low-Intensity Shockwave Therapy for Erectile Dysfunction in Patients Who Do Not Respond to Phosphodiesterase Type 5 Inhibitors. Sex Med 2016. [Epub ahead of print]. [Crossref] [PubMed]
8. Reisman Y, Hind A, Varaneckas A, et al. Initial experience with linear focused shockwave treatment for erectile dysfunction: a 6-month follow-up pilot study. Int J Impot Res 2015;27:108-12. [Crossref] [PubMed]
9. Ruffo A, Capece M, Prezioso D, et al. Safety and efficacy of low intensity shockwave (LISW) treatment in patients with erectile dysfunction. Int Braz J Urol 2015;41:967-74. [Crossref] [PubMed]
10. Pelayo-Nieto M, Linden-Castro E, Alias-Melgar A, et al. Linear shock wave therapy in the treatment of erectile dysfunction. Actas Urol Esp 2015;39:456-9. [Crossref] [PubMed]
11. Angulo JC, Arance I, de Las Heras MM, et al. Efficacy of low-intensity shock wave therapy for erectile dysfunction: A systematic review and meta-analysis. Actas Urol Esp 2016. [Epub ahead of print]. [PubMed]
12. Fojecki GL, Tiessen S, Osther PJ. Extracorporeal shock wave therapy (ESWT) in urology: a systematic review of outcome in Peyronie's disease, erectile dysfunction and chronic pelvic pain. World J Urol 2016. [Epub ahead of print]. [Crossref] [PubMed]
13. Lu Z, Lin G, Reed-Maldonado A, et al. Low-intensity Extracorporeal Shock Wave Treatment Improves Erectile Function: A Systematic Review and Meta-analysis. Eur Urol 2016. [Epub ahead of print]. [Crossref]
14. Assaly-Kaddoum R, Giuliano F, Laurin M, et al. Low Intensity Extracorporeal Shock Wave Therapy Improves Erectile Function in a Model of Type II Diabetes Independently of NO/cGMP Pathway. J Urol 2016;196:950-6. [Crossref] [PubMed]
15. Qiu X, Lin G, Xin Z, et al. Effects of low-energy shockwave therapy on the erectile function and tissue of a diabetic rat model. J Sex Med 2013;10:738-46. [Crossref] [PubMed]
16. Liu J, Zhou F, Li GY, et al. Evaluation of the effect of different doses of low energy shock wave therapy on the erectile function of streptozotocin (STZ)-induced diabetic rats. Int J Mol Sci 2013;14:10661-73. [Crossref] [PubMed]
17. Aicher A, Heeschen C, Sasaki K, et al. Low-energy shock wave for enhancing recruitment of endothelial progenitor cells: a new modality to increase efficacy of cell therapy in chronic hind limb ischemia. Circulation 2006;114:2823-30. [Crossref] [PubMed]
18. Di Meglio F, Nurzynska D, Castaldo C, et al. Cardiac shock wave therapy: assessment of safety and new insights into mechanisms of tissue regeneration. J Cell Mol Med 2012;16:936-42. [Crossref] [PubMed]
19. Nishida T, Shimokawa H, Oi K, et al. Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia-induced myocardial dysfunction in pigs in vivo. Circulation 2004;110:3055-61. [Crossref] [PubMed]
20. Nurzynska D, Di Meglio F, Castaldo C, et al. Shock waves activate in vitro cultured progenitors and precursors of cardiac cell lineages from the human heart. Ultrasound Med Biol 2008;34:334-42. [Crossref] [PubMed]
21. Zins SR, Amare MF, Tadaki DK, et al. Comparative analysis of angiogenic gene expression in normal and impaired wound healing in diabetic mice: effects of extracorporeal shock wave therapy. Angiogenesis 2010;13:293-304. [Crossref] [PubMed]
22. Hausner T, Pajer K, Halat G, et al. Improved rate of peripheral nerve regeneration induced by extracorporeal shock wave treatment in the rat. Exp Neurol 2012;236:363-70. [Crossref] [PubMed]
23. Mense S, Hoheisel U. Shock wave treatment improves nerve regeneration in the rat. Muscle Nerve 2013;47:702-10. [Crossref] [PubMed]
24. Li H, Matheu MP, Sun F, et al. Low-energy Shock Wave Therapy Ameliorates Erectile Dysfunction in a Pelvic Neurovascular Injuries Rat Model. J Sex Med 2016;13:22-32. [Crossref] [PubMed]